The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-cyclopropyl-6-fluoro-4-oxo-7-(4-(1-oxo-1-(4-sulfamoylphenylamino)propan-2-yl)piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid ID: ALA5076830
PubChem CID: 166626267
Max Phase: Preclinical
Molecular Formula: C26H28FN5O6S
Molecular Weight: 557.60
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C(=O)Nc1ccc(S(N)(=O)=O)cc1)N1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1
Standard InChI: InChI=1S/C26H28FN5O6S/c1-15(25(34)29-16-2-6-18(7-3-16)39(28,37)38)30-8-10-31(11-9-30)23-13-22-19(12-21(23)27)24(33)20(26(35)36)14-32(22)17-4-5-17/h2-3,6-7,12-15,17H,4-5,8-11H2,1H3,(H,29,34)(H,35,36)(H2,28,37,38)
Standard InChI Key: NYLIGQXHXGYNAU-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 43 0 0 0 0 0 0 0 0999 V2000
18.1268 -21.4905 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5395 -20.7847 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
17.7219 -20.7802 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.6122 -19.9964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6110 -20.8159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3191 -21.2249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3173 -19.5875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0259 -19.9928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0247 -20.8180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7348 -21.2293 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.4506 -20.8200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4518 -19.9948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7372 -19.5789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1605 -19.5880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8672 -19.9983 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.1625 -18.7708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.7325 -22.0465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7372 -18.7617 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.3257 -22.7531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1428 -22.7554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9044 -19.5880 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.9030 -21.2240 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.1993 -20.8104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4934 -21.2149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4885 -22.0324 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.1957 -22.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9078 -22.0376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7789 -22.4378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0731 -22.0260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3635 -22.4313 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.6577 -22.0195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0769 -21.2088 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.6651 -21.2020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9601 -20.7903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2496 -21.1957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2485 -22.0171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9541 -22.4251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5459 -19.9676 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.7752 -23.2550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
12 14 1 0
14 15 1 0
14 16 2 0
10 17 1 0
13 18 2 0
19 17 1 0
20 19 1 0
17 20 1 0
4 21 1 0
5 22 1 0
22 23 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
25 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
29 32 2 0
31 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 31 1 0
35 2 1 0
2 38 1 0
28 39 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 557.60Molecular Weight (Monoisotopic): 557.1744AlogP: 1.97#Rotatable Bonds: 7Polar Surface Area: 155.04Molecular Species: ACIDHBA: 8HBD: 3#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 5.66CX Basic pKa: 4.83CX LogP: 1.66CX LogD: 0.19Aromatic Rings: 3Heavy Atoms: 39QED Weighted: 0.40Np Likeness Score: -1.45
References 1. Ibrahim NM, Fahim SH, Hassan M, Farag AE, Georgey HH.. (2022) Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects., 228 [PMID:34871841 ] [10.1016/j.ejmech.2021.114021 ]